| 000 | 01447 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517073729.0 | ||
| 264 | 0 | _c20171017 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.13433 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoyce, M | |
| 245 | 0 | 0 |
_aSafety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _c05 2016 |
||
| 300 |
_a1580-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 |
_aHepcidins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIron _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOligoribonucleotides _xadministration & dosage |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTransferrin _xanalysis |
| 700 | 1 | _aWarrington, S | |
| 700 | 1 | _aCortezi, B | |
| 700 | 1 | _aZöllner, S | |
| 700 | 1 | _aVauléon, S | |
| 700 | 1 | _aSwinkels, D W | |
| 700 | 1 | _aSummo, L | |
| 700 | 1 | _aSchwoebel, F | |
| 700 | 1 | _aRiecke, K | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 173 _gno. 10 _gp. 1580-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.13433 _zAvailable from publisher's website |
| 999 |
_c25635910 _d25635910 |
||